Dependency of the trans vivo delayed type hypersensitivity response on the action of regulatory T cells: Implications for monitoring transplant tolerance

Transplantation

Volumn 84, Issue 3, 2007, Pages 392-399

  Warnecke, Gregor ^a,b,c   Chapman, Stephanie J ^a,c   Bushell, Andrew ^a   Hernandez Fuentes, Maria ^c   Wood, Kathryn J ^a,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Indices of Tolerance Study Group

Author keywords

Delayed type hypersensitivity; Mouse heart transplantation; Regulatory T cells; Tolerance assay

Indexed keywords

ALLOANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; MONOCLONAL ANTIBODY YTS 177; OKT 4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 10 MOUSE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL PROTOCOL; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; GRAFT RECIPIENT; GRAFT REJECTION; HEART GRAFT; IMMUNE DEFICIENCY; IMMUNE STATUS; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; LEUKOCYTE; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SCID MOUSE; SWELLING; TREATMENT OUTCOME;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HYPERSENSITIVITY, DELAYED; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; ISOANTIGENS; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE;

EID: 34547895869     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000269705.94545.3a     Document Type: Article

References (27)

1. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000; 106: 145.
2. Carrodeguas L, Orosz CG, Waldman WJ, et al. Trans vivo analysis of human delayed-type hypersensitivity reactivity. Hum Immunol 1999; 60: 640.
3. Geissler F, Jankowska-Gan E, DeVito-Haynes LD, et al. Human liver allograft acceptance and the "tolerance assay": In vitro anti-donor T cell assays show hyporeactivity to donor cells, but unlike DTH, fail to detect linked suppression. Transplantation 2001; 72: 571.
4. Jankowska-Gan E, Rhein T, Haynes LD, et al. Human liver allograft acceptance and the "tolerance assay." II. Donor HLA-A, -B but not DR antigens are able to trigger regulation of DTH. Hum Immunol 2002; 63: 862.
5. Cai J, Lee J, Jankowska-Gan E, et al. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 2004; 199: 1017.
6. Bickerstaff A, Orosz C. Evidence for a limited contribution of immune regulation to cardiac allograft acceptance. Hum Immunol 2002; 63: 935.
7. Bickerstaff AA, Wang JJ, Xia D, Orosz CG. Allograft acceptance despite differential strain-specific induction of TGF-beta/IL-10-mediated immunoregulation. Am J Transplant 2002; 2: 819.
8. Hara M, Kingsley CI, Niimi M, et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 3789.
9. Zheng XX, Markees TG, Hancock WW, et al. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment. J Immunol 1999; 162: 4983.
10. Kingsley CI, Karim M, Bushell AR, Wood KJ. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080.
11. Qin SX, Wise M, Cobbold SP, et al. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur J Immunol 1990; 20: 2737.
12. Leach DR, Krummel MF, Allison JP. Enhancement of antitumor immunity by CTLA-4 blockade. Science 1996; 271: 1734.
13. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
14. Saitovitch D, Bushell A, Mabbs DW, et al. Kinetics of induction of transplantation tolerance with a nondepleting anti-Cd4 monoclonal antibody and donor-specific transfusion before transplantation. A critical period of time is required for development of immunological unresponsiveness. Transplantation 1996; 61: 1642.
15. van Maurik A, Herber M, Wood KJ, Jones ND. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: Implications for anti-CD154 immunotherapy. J Immunol 2002; 169: 5401.
16. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057.
17. Vella JP, Vos L, Carpenter CB, Sayegh MH. Role of indirect allorecognition in experimental late acute rejection. Transplantation 1997; 64: 1823.
18. Wise MP, Bemelman F, Cobbold SP, Waldmann H. Linked suppression of skin graft rejection can operate through indirect recognition. J Immunol 1998; 161: 5813.
19. Yamada A, Chandraker A, Laufer TM, et al. Recipient MHC class II expression is required to achieve long-term survival of murine cardiac allografts after costimulatory blockade. J Immunol 2001; 167: 5522.
20. Hornick PI, Mason PD, Yacoub MH, et al. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation 1998; 97: 1257.
21. Baker RJ, Hernandez-Fuentes MP, Brookes PA, et al. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: Implications for the pathogenesis of chronic allograft nephropathy. J Immunol 2001; 167: 7199.
22. Chalermskulrat W, Neuringer IP, Brickey WJ, et al. Hierarchical contributions of allorecognition pathways in chronic lung rejection. Am J Respir Crit Care Med 2003; 167: 999.
23. Lau CL, Patterson GA. Current status of lung transplantation. Eur Respir J Suppl 2003; 47: 57s.
24. Valujskikh A, VanBuskirk AM, Orosz CG, Heeger PS. A role for TGF-beta and B cells in immunologic tolerance after intravenous injection of soluble antigen. Transplantation 2001; 72: 685.
25. Bickerstaff AA, VanBuskirk AM, Wakely E, Orosz CG. Transforming growth factor-beta and interleukin-10 subvert alloreactive delayed type hypersensitivity in cardiac allograft acceptor mice. Transplantation 2000; 69: 1517.
26. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287.
27. VanBuskirk AM, Wakely ME, Sirak JH, Orosz CG. Patterns of allosensitization in allograft recipients: Long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity. Transplantation 1998; 65: 1115.